Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
Motor with power-generation coil module
Pet grooming brush and vacuum attachment
Systems, methods, and devices for selling transaction instruments via web-based tool
Virtual billboards
Using sets of OTDR receive fibers with different lengths of marker events to verify optical fiber connectivity
Image forming apparatus assembled with a fixing member and a pressing member
Driver circuit for driving semiconductor switches
  Randomly Featured Patents
Method of sythesizing carbon film and carbon particles in a vapor phase
Capillary columns employing monodispersed particles
System and method for providing emergency information
Semiconductor package
Method of wiring formation and method for manufacturing electronic components
Piperazine derivatives as 5-HT antagonists
Fluidic connector
Wearable transmission device
Audio segmentation and classification
Textile structures containing linear low density polyethylene binder fibers